THERAPEUTIC SEGMENT:
Oral Antidiabetic

INDICATIONS:
Type 2 diabetes mellitus.

BRIEF DESCRIPTION:
Scicon-MR (Gliclazide) is an oral antidiabetic agent containing a modified release version of the active ingredient Gliclazide. Scicon-MR belongs to a class of oral hypoglycemic agents known as sulphonylureas and is used to help control blood glucose levels in patients with Type 2 diabetes.

DOSAGE FORM:

Tablets

30mg
60mg